Transportation Secretary Jaime Bautista said the department is nearing a resolution to the right-of-way issue of Phase 2 of ...

Vision Net, a leading provider of network and technology solutions for carriers, enterprise businesses, healthcare organizations, and educational institutions, announced a series of significant ...

Shares of Vir Biotechnology (CIR) climbed ~42% in the premarket on Wednesday after the company posted initial Phase 1 data ...

The first MAPS 4 bus stop improvements are complete and open for service in northeast Oklahoma City.According to the City of Oklahoma City, the project will imp ...

The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small ...

With an aggregate of $11 million raised in an initial Series A funding round, Doron Therapeutics is advancing its lead ...

Kelantan State Development Action Council joint chairman Nik Nazmi Nik Ahmad says this is in line with Prime Minister Anwar ...

Airtel, with industry-leading ARPU and subscriber growth, may also see a 60 basis points (bps) growth in operating profit ...

Results support advancing LB-102 to Phase 3 clinical development in schizophrenia . NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...

Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has ...

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...